Ownership Submission
FORM 3
 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Expires: January 31, 2005
Estimated average burden hours per response... 0.5

(Print or Type Responses)
1. Name and Address of Reporting Person *
  RICHO ANNA
 2. Date of Event Requiring Statement (Month/Day/Year)
06/03/2008		 3. Issuer Name and Ticker or Trading Symbol
AMGEN INC [AMGN]
(Last)
(First)
(Middle)
ONE AMGEN CENTER DRIVE		 4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director _____ 10% Owner
__X__ Officer (give title below) _____ Other (specify below)
SVP. WW Compliance
 5. If Amendment, Date Original Filed(Month/Day/Year)
(Street)

THOUSAND OAKS, CA 91320-1799		 6. Individual or Joint/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
(City)
(State)
(Zip)
Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4)		 2. Amount of Securities Beneficially Owned
(Instr. 4)		 3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)		 4. Nature of Indirect Beneficial Ownership
(Instr. 5)
Common Stock 1,464
D
 
Common Stock 1,251.229 (1)
D
 
Common Stock (2) 13,372
D
 

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. SEC 1473 (7-02)
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 4)		 2. Date Exercisable and Expiration Date
(Month/Day/Year)		 3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)		 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)		 6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
ISO (Right to Buy) 12/01/2004(3) 12/01/2010 Common Stock 5,064 $ 59.23 D  
ISO (Right to Buy) 03/15/2008(4) 03/15/2011 Common Stock 3,362 $ 59.48 D  
ISO (Right to Buy) 04/26/2011 04/26/2014 Common Stock 1,598 $ 62.55 D  
ISO (Right to Buy) 04/03/2010 04/03/2013 Common Stock 1,391 $ 71.88 D  
NQSO (Right to Buy) 03/15/2006(5) 03/15/2012 Common Stock 8,571 $ 58.61 D  
NQSO (Right to Buy) 12/01/2004(6) 12/01/2010 Common Stock 9,936 $ 59.23 D  
NQSO (Right to Buy) 03/15/2005(7) 03/15/2011 Common Stock 3,706 $ 59.48 D  
NQSO (Right to Buy) 04/26/2008(8) 04/26/2014 Common Stock 10,902 $ 62.55 D  
NQSO (Right to Buy) 04/03/2007(9) 04/03/2013 Common Stock 6,484 $ 71.88 D  
NQSO (Right to Buy) 04/29/2009(10) 04/29/2015 Common Stock 11,800 $ 42.13 D  

Reporting Owners

Reporting Owner Name / Address Relationships
Director 10% Owner Officer Other
RICHO ANNA
ONE AMGEN CENTER DRIVE
THOUSAND OAKS, CA 91320-1799		       SVP. WW Compliance  

Signatures

/s/ N. Cris Prince, Attorney-in-Fact 06/12/2008
**Signature of Reporting Person Date

Explanation of Responses:

* If the form is filed by more than one reporting person, see Instruction 5(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1) These are units acquired under the Company's 401(k) Plan and represent interests in the Company's stock fund as of this filing.
(2) The Restricted Stock Units (RSUs) were granted under the Company's Amended and Restated 1991 Equity Incentive Plan 10,000 RSUs vest in four equal annual installments of 2,500 shares each commencing July 17, 2008, and 3,372 RSUs vest in four equal annual installments of 843 shares each commencing April 29, 2009. Vested RSU's will be paid in shares of the Company's common stock on a one-to-one basis.
(3) This option was fully exercisable on December 1, 2007.
(4) This option is exercisable as follows: 1,681 shares immediately; and 1,681 shares on March 15, 2009.
(5) This option is exercisable as follows: 6,428 shares immediately; and 2,143 shares on March 15, 2009.
(6) This option was fully exercisable on December 1, 2007.
(7) This option is exercisable as follows: 3,620 shares immediately; and 86 shares on March 15, 2009.
(8) This Option is exercisable as follows: 3,125 shares immediately; 3,125 shares on April 26, 2009; 3,125 shares on April 26, 2010; and 1,527 shares on April 26, 2011.
(9) This option is exercisable as follows: 3,937 shares immediately; 1,969 shares on April 3, 2009; and 578 shares on April 3, 2010.
(10) This option is exercisable in four equal annual installments of 2,950 each commencing April 29, 2009.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, See Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.